Literature DB >> 10958115

PHNO, a selective dopamine D2 receptor agonist, does not reduce prepulse inhibition of the startle reflex in rats.

M T Martin-Iverson1, D Else.   

Abstract

RATIONALE: Dopamine agonists nonselective for dopamine receptor subtypes, such as apomorphine, reduce prepulse inhibition of the startle reflex. It has been suggested that either D2 or D3 dopamine receptors mediate this action of apomorphine.
OBJECTIVE: The present study investigated whether a selective D2 agonist with relatively low affinity for D3 receptors can reduce prepulse inhibition.
METHODS: Rats (n=48) were treated with vehicle or one of three doses ( 15, 30 or 60 microg/kg, s.c.) of the specific dopamine D2 receptor agonist (+)-4-propyl-9-hydroxynaphthoxazine (PHNO) for 11 days. On days 1, 6 and 11 of treatment, the rats (n=12 in each group) were tested for their acoustic startle reflexes (105-dB, 40-ms white noise) and for prepulse inhibition (5-kHz tone, 5 dB above a 65 dB background white noise). Prepulses were presented with a range of stimulus onset asynchronies (SOAs: 5-160 ms) or lead times between the onset of the prepulse and the onset of the startle stimulus. In a second experiment, two groups of rats (n=10 in each group) were tested in a similar manner after vehicle or apomorphine (0.8 mg/kg, s.c.) to verify the sensitivity of the present procedure to agonist-induced reductions in prepulse inhibition.
RESULTS: At doses that increased motor activity, PHNO increased prepulse inhibition at SOAs less than 80 ms and had no effect on prepulse inhibition at SOAs of 80 ms or above. However, all doses decreased startle amplitudes on trials in which only the startle-eliciting stimulus was presented. Apomorphine reduced prepulse inhibition under the same conditions.
CONCLUSIONS: These findings with PHNO are in contrast to the less-specific D2 agonist, quinpirole, which has been reported to decrease prepulse inhibition. It is concluded that activation of D2 dopamine receptors alone is not sufficient to attenuate prepulse inhibition of the startle reflex.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10958115     DOI: 10.1007/s002130000483

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  8 in total

1.  Heritable differences in the dopaminergic regulation of sensorimotor gating. II. Temporal, pharmacologic and generational analyses of apomorphine effects on prepulse inhibition.

Authors:  Neal R Swerdlow; Jody M Shoemaker; Pamela P Auerbach; Leia Pitcher; Jana Goins; Amanda Platten
Journal:  Psychopharmacology (Berl)       Date:  2003-05-21       Impact factor: 4.530

2.  Interaction between the effects of corticotropin-releasing factor and prepulse parameters on prepulse inhibition in two inbred rat strains and the F1 generation of a cross between them.

Authors:  Lisa H Conti; Jane E Sutherland; Carey M Muhlhauser
Journal:  Behav Brain Res       Date:  2009-06-08       Impact factor: 3.332

3.  Inhibition of 5α-reductase attenuates behavioral effects of D1-, but not D2-like receptor agonists in C57BL/6 mice.

Authors:  Roberto Frau; Giuliano Pillolla; Valentina Bini; Simone Tambaro; Paola Devoto; Marco Bortolato
Journal:  Psychoneuroendocrinology       Date:  2012-08-09       Impact factor: 4.905

4.  Apomorphine effects on emotional modulation of the startle reflex in rats.

Authors:  Mathew T Martin-Iverson; Kirsten N Stevenson
Journal:  Psychopharmacology (Berl)       Date:  2005-10-15       Impact factor: 4.530

5.  Strain differences in the disruption of prepulse inhibition of startle after systemic and intra-accumbens amphetamine administration.

Authors:  Neal R Swerdlow; Jody M Shoemaker; Michele J Bongiovanni; Alaina C Neary; Laura S Tochen; Richard L Saint Marie
Journal:  Pharmacol Biochem Behav       Date:  2007-04-03       Impact factor: 3.533

6.  Effect of apomorphine on cognitive performance and sensorimotor gating in humans.

Authors:  Arnt F A Schellekens; K P Grootens; C Neef; Kris L L Movig; J K Buitelaar; B Ellenbroek; R J Verkes
Journal:  Psychopharmacology (Berl)       Date:  2009-10-16       Impact factor: 4.530

7.  Dexamphetamine effects on prepulse inhibition (PPI) and startle in healthy volunteers.

Authors:  Kate Chitty; Matthew A Albrecht; Kyran Graham; Chantelle Kerr; Joseph W Y Lee; Rajan Iyyalol; Mathew T Martin-Iverson
Journal:  Psychopharmacology (Berl)       Date:  2013-12-18       Impact factor: 4.530

8.  Effects of Neonatal Dexamethasone Exposure on Adult Neuropsychiatric Traits in Rats.

Authors:  Nathanael J Yates; Donald Robertson; Jennifer Rodger; Mathew T Martin-Iverson
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.